How severe is CVE-2023-7134?

CVE-2023-7134 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.

Is CVE-2023-7134 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (57th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2023-7134?

CVE-2023-7134 affects Oretnom23 Medicine Tracker System. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2023-7134?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

When was CVE-2023-7134 published?

CVE-2023-7134 was published on 2023-12-28 and last updated on 2026-06-17.

CVE-2023-7134

CVE-2023-7134 is a medium-severity vulnerability in Oretnom23 Medicine Tracker System with a CVSS 3.x base score of 6.3. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-22.

Key facts

Severity: Medium (CVSS 3.x base score 6.3)
CVSS v2: 6.5
EPSS exploit prediction: 1% (57th percentile)
Actively exploited: Not listed in CISA KEV
Weakness: CWE-22
Affected product: Oretnom23 Medicine Tracker System
Published: 2023-12-28
Last modified: 2026-06-17

Description

A vulnerability was found in SourceCodester Medicine Tracking System 1.0. It has been rated as critical. This issue affects some unknown processing. The manipulation of the argument page leads to path traversal: '../filedir'. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-249137 was assigned to this vulnerability.

Frequently asked questions

What is CVE-2023-7134?: A vulnerability was found in SourceCodester Medicine Tracking System 1.0. It has been rated as critical. This issue affects some unknown processing. The manipulation of the argument page leads to path traversal: '../filedir'. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-249137 was assigned to this vulnerability.
How severe is CVE-2023-7134?: CVE-2023-7134 has a CVSS 3.x base score of 6.3, rated medium severity. It is exploitable over network with low attack complexity, requires low privileges and no user interaction. Impact on confidentiality is low, integrity low, and availability low.
Is CVE-2023-7134 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 1% (57th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2023-7134?: CVE-2023-7134 affects Oretnom23 Medicine Tracker System. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2023-7134?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
When was CVE-2023-7134 published?: CVE-2023-7134 was published on 2023-12-28 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:oretnom23:medicine_tracker_system:1.0:*:*:*:*:*:*:*

More vulnerabilities in Oretnom23 Medicine Tracker System

CVE-2024-6418 — High (CVSS 7.3): A vulnerability classified as critical has been found in SourceCodester Medicine Tracker System 1.0. This affects an…
CVE-2024-6419 — Medium (CVSS 6.3): A vulnerability classified as critical was found in SourceCodester Medicine Tracker System 1.0. This vulnerability…
CVE-2023-7123 — Medium (CVSS 6.3): A vulnerability, which was classified as critical, has been found in SourceCodester Medicine Tracking System 1.0. This…
CVE-2024-7226 — Medium (CVSS 4.3): A vulnerability was found in SourceCodester Medicine Tracker System 1.0. It has been declared as problematic. This…
CVE-2023-5581 — Low (CVSS 3.5): A vulnerability classified as problematic was found in SourceCodester Medicine Tracker System 1.0. This vulnerability…

All CVEs affecting Oretnom23 Medicine Tracker System →

Other CWE-22 (Path Traversal) vulnerabilities

CVE-2026-48282 — Critical (CVSS 10.0): ColdFusion versions 2025.9, 2023.20 and earlier are affected by an Improper Limitation of a Pathname to a Restricted…
CVE-2026-54917 — Critical (CVSS 10.0): SeaweedFS is a distributed storage system for object storage (S3), file systems, and Iceberg tables. Prior to 4.30, the…
CVE-2026-11429 — Critical (CVSS 10.0): Two endpoints in the Vault Service ScriptsController, shared by Altium Enterprise Server and Altium 365, accept file…
CVE-2026-34909 — Critical (CVSS 10.0): A malicious actor with access to the network could exploit a Path Traversal vulnerability found in UniFi OS devices to…
CVE-2026-7411 — Critical (CVSS 10.0): In Eclipse BaSyx Java Server SDK versions prior to 2.0.0-milestone-10, inadequate path normalization in the Submodel…
CVE-2026-36767 — Critical (CVSS 10.0): A path traversal vulnerability in the /content/images/add endpoint of shopizer v3.2.5 allows attackers write arbitrary…

Browse all CWE-22 (Path Traversal) vulnerabilities →